Clinical Trial Detail

NCT ID NCT02047747
Title A Phase II Study of Dacomitinib in Progressive Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors David Piccioni, M.D., Ph.D
Indications

lung cancer

breast cancer

melanoma

stomach cancer

Therapies

Dacomitinib

Age Groups: adult senior

Additional content available in CKB BOOST